YBX1 and breast carcinoma: To date, YBX1 has been shown to be phosphorylated only on S102 after insulin growth factor 1 (IGF-1) treatment [10], an event that fundamentally affects YBX1 function in human breast cancer MCF7 cells [10, 11].